Quarterly report pursuant to Section 13 or 15(d)

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)

v3.24.3
ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)
9 Months Ended
Sep. 30, 2024
ACCOUNTS PAYABLE AND ACCRUED EXPENSES  
Summary of accounts payable and accrued expenses

    

September 30, 2024

    

December 31, 2023

Accrued research and development

$

2,968,508

$

2,263,934

Accrued compensation expenses

 

247,210

 

716,307

Accrued professional fees

 

83,950

 

58,388

Other accounts payable and accrued expenses

 

19,097

 

3,809

Total

$

3,318,765

$

3,042,438